NR4A1 and breast carcinoma: The Study of Anastrozole with the Bisphosphonate Risedronate evaluated the effects of risedronate on bmd and bone turnover in postmenopausal women using anastrozole as adjuvant therapy for hormone receptor–positive early breast cancer 49.